Partner with us:
We are seeking for partnerships, collaborations and investors  “our USPs”

Supported by:

ABS Biotechnologies received AWS PreSeed funding from BMDW. This six-digit euro, non-dilutive funding opens the door for ABS to get started, speeding up the development of its drug screening assay platforms/MVPs and commercial partnerships.

Accent Incubator GmbH

Austrian Business Agency (ABA)

Innovation Forum Accelerator

ABS Biotechnologies: The Winner of Cambridge IMAGINE IF! Programme 2021
https://cambridge.inno-forum.org/event/imagine-if-cambridge-local-finals/
https://www.linkedin.com/feed/update/urn:li:activity:6795774687822520320/